QT
RLAY icon

Quantbot Technologies’s Relay Therapeutics RLAY Stock Holding History

Quantbot Technologies’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
23,958
+22,904
+2,173% +$332K 0.02% 969
2026
Q1 		$10.5K Buy
+1,054
New +$9.43K ﹤0.01% 1533
2023
Q4 		– Sell
-23,200
Closed -$195K – 1925
2023
Q3 		$195K Buy
+23,200
New +$249K 0.01% 911
2023
Q1 		– Sell
-16,222
Closed -$242K – 1988
2022
Q4 		$242K Buy
16,222
+4,922
+44% +$94.2K 0.02% 827
2022
Q3 		$252K Buy
+11,300
New +$248K 0.02% 809
2022
Q1 		– Sell
-100
Closed -$3K – 1988
2021
Q4 		$3K Sell
100
-4,700
-98% -$149K ﹤0.01% 1411
2021
Q3 		$151K Buy
+4,800
New +$162K 0.01% 874

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Quantbot Technologies's RLAY Position: Q2 2026 in Review

Quantbot Technologies increased its Relay Therapeutics (RLAY) stake by 2,173% in Q2 2026, buying an estimated $332K and bringing the position to 23,958 shares worth $448K. The position accounts for 0.02% of the portfolio, ranked #969.

Quantbot Technologies first reported a position in RLAY in Q3 2021 and has held it in 7 quarters since. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Quantbot Technologies held 23,958 shares of Relay Therapeutics worth $448K as of Q2 2026.
  • Quantbot Technologies bought 22,904 Relay Therapeutics shares in Q2 2026, an estimated $332K.
  • Relay Therapeutics made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #969 holding.
  • Quantbot Technologies first reported a position in Relay Therapeutics in Q3 2021 and has held it in 7 quarters since.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.